Exagen news and milestones

Exagen: 11 headlines on record, 0 headlines in the last 90 days. Its story counts 8 milestones.

Data updated Nov 15, 2026 · Back to the company report

11Headlines

0In 90 days

8Milestones

Headlines

Jun 12026

News · markets.ft.com

Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus - Company Announcement - FT.com

The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.

May 112026

Press release · The Manila Times

Exagen Inc. Reports First Quarter 2026 Results

Delivers record total revenue and AVISE(R) CTD average selling price

Apr 132026

News · YahooFinance

Does Exagen (XGN)'s 200%+ Upside Potential Make It One of the Best Penny Stocks Set to Explode?

Exagen Inc. (NASDAQ:XGN) earns a spot on our list of the best penny stocks set to explode. As of April 8, 2026, analyst sentiment toward Exagen Inc. (NASDAQ:XGN) remains bullish,…

Mar 102026

Press release · The Manila Times

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results

Record full-year total revenue and AVISE CTD average selling price

Sep 13, 20252025

News · seekingalpha.com

Exagen's Momentum Meets Execution Risks: Why I Choose To HOLD For Now

Jun 22, 20252025

News · Nasdaq

Exagen Inc. Appoints Dr. Michael Mahler as Chief Scientific Officer to Enhance Autoimmune Diagnostic Innovations

Exagen Inc. appoints Dr. Michael Mahler as Chief Scientific Officer to enhance autoimmune diagnostics and patient care.

Apr 26, 20252025

News · seekingalpha.com

Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability

Aug 20, 20242024

Blog

real-world evidence conﬁrms that AVISE testing enables decisive clinical action superior to the current standard of care

The post real-world evidence conﬁrms that AVISE testing enables decisive clinical action superior to the current standard of care appeared first on Exagen Inc..

Mar 24, 20202020

Blog

Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer

SAN DIEGO, March 24, 2020 - Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announc…

Mar 16, 20202020

Blog

Exagen Inc. Partners with Sonora Quest Laboratories to Offer AVISE Testing for Patients Suspected of Autoimmune Disease

SAN DIEGO, CA, - Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases…

Mar 9, 20202020

Blog

Exagen Inc. Partners with Three California Medical Groups to Offer AVISE Testing as Covered In-Network Benefit for Their Patients

SAN DIEGO, CA - Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases b…

Sources: the outlets named on each headline, each story once